Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
ENALAPRIL ARENA 20 mg
Angiotensin-converting enzyme inhibitor, indicated in arterial hypertension and heart failure
Active Substance (INN)
ENALAPRILUM
Packaging
3, 5, 10, 100 blisters x 10 tablets
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.